GLP-1 Market: Industry Trends and Global Forecasts, till 2035 Distribution by Type of Molecule (Biologics and Small Molecules), Active Compound Used (Dulaglutide, Liraglutide, Orforglipron, Retatrutide, Semaglutide, Survodutide, Tirzepatide and Other Active Compounds), Type of GLP-1 Agonist Drugs (Long-acting GLP-1 Agonist and Short-acting GLP-1 Agonist), Type of Agonist (Single-agonist, Dual-agonist and Tri-agonist) Route of Administration (Oral and Parenteral), Target indication (Alzheimers Disease, Non-Alcoholic Steatohepatitis, Obesity, Sleep Apnea, Type 2 Diabetes), Geography (North America, Europe, Asia Pacific and Latin America), Leading Drug Developers and Sales Forecast
The GLP-1 Market is expected to reach USD 49.3 billion by 2024 anticipated to grow at a CAGR of 11.1% during the forecast period 2024-2035.GLP-1 receptor agonists are a class of medications primarily used to manage blood sugar levels in individuals with t…
Pharmacy Market: Industry Trends and Global Forecasts, till 2035: Distribution by Type of Pharmacy (Retail Pharmacy, e-pharmacy, Hospital Pharmacy, Other Pharmacies), Type of Product Offered (Drugs / Pharmaceuticals, Medical Devices and Other Pharmacy Products), Availability (Prescription Products and Over-the-counter Products), Type of Drug (Branded / Patented Drugs and Generic Drugs), Type of Drug Molecule (Small Molecules and Biologics), Type of e-pharmacy Platforms (App-based Platforms and Web-based Platforms), Therapeutic Area (Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Diseases, Metabolic Disorders, Respiratory Disorders, Dermatological Disorders, Genetic Disorders, Autoimmune / Inflammatory Disorders and Other Disorders), Key Players and Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America)
The Pharmacy Market is expected to reach USD 2.4 trillion by 2024 anticipated to grow at a CAGR of 5% during the forecast period 2024-2035.A recent study investigates the pharmacy industry, analyzing trends, market dynamics, competitive landscape, company…
Report Details
The Rare Diseases Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies t…
Report Details
The Cell Therapy Technologies Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for…
Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material (Glass, Stainless Steel and Single use), Type of Bioprocess (Batch, Fed-batch and Continuous), Type of Biologic (Antibodies, Vaccines, Cell Therapies and Other Biologics), and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World)
Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material (Glass, Stainless Steel and Single use), Type of Bioprocess (Batch, Fed-batch and Continuous), Type of Biologic (Antibodies, Vaccines, Cell Therapie…
Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications (Atypical Hemolytic Uremic Syndrome, Fabry Disease, Immunoglobulin A Nephropathy, Focal Segmental Glomerulosclerosis, Autosomal Dominant Polycystic Kidney Disease, Lupus Nephritis and Others), Type of Molecule (Small Molecules and Biologics), Type of Biologics (Monoclonal Antibodies and Proteins), Route of Administration (Oral, Intravenous, Subcutaneous, and Others), Type of Therapy (Monotherapy, Combination Therapy), Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World), Leading Drug Developers and Sales Forecast
Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications (Atypical Hemolytic Uremic Syndrome, Fabry Disease, Immunoglobulin A Nephropathy, Focal Segmental Glomerulosclerosis, Autosomal Domina…
Report Details
The Orphan Drugs Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies th…
Global Psoriatic Arthritis Treatment Market Size study & Forecast, by Drug Type (NSAIDs, DMARDs, Biologics, and Others), Type (Prescription, and OTC), and Route of Administration (Topical, Oral, and Injectable) and Regional Analysis, 2022-2029
Global Psoriatic Arthritis Treatment Market is valued approximately USD 9.61 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.2% over the forecast period 2022-2029. Psoriatic Arthritis is a form of arthritis that occurs…
Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases (I to IV), Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs) - Global Forecast 2027
The Global Clinical Trial Supplies market is projected to reach USD 5.7 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 9.7% during the forecast period of 2022 to 2027. Factors such a as globalization of clinical trials and growing R&D expendit…
The global aseptic pharma processing market is expected to grow at a significant rate during the forecast period. The growth can be attributed to the rising demands for prolonged shelf-life of drugs, medicines, therapeutic creams, and other biological pro…
Global Plant Based Biomanufacturing Market, By Product Type (Antibodies, Vaccines, Proteins, Biologics, Enzyme, Others), By Technology (Upstream v/s Downstream) By Source (Whole Plant, Plant Cells, Seed, Leaf, Others), By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations, Others), By Region, Competition Forecast & Opportunities, 2026
Global plant based biomanufacturing market will report an impressive CAGR in the forecast period, 2022-2026. The market growth can be attributed to the advancing healthcare capabilities to device treatment from plant based elements. Moreover, increasing n…
The global wound care biologics market is valued at an estimated USD 1.8billion in 2022 and is projected to reach USD 2.4billion by 2027, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such asthe growing incidence of burn…
As the global economy mends, the 2021 growth of Biologics Contract Manufacturing will have significant change from previous year. According to our (LP Information) latest study, the global Biologics Contract Manufacturing market size is USD million in 202…
Report Scope:The report summarizes the market, including a market snapshot and company profiles of key players in the sole-use technologies market. It provides a comprehensive market breakdown with in-depth information about each segment. The overview sec…
The global biologics market reached a value of US$ 294 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 501.9 Billion by 2027, exhibiting a CAGR of 9.25% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are …
Market Analysis and Insights: Global Biopharmaceuticals Excipients MarketDue to the COVID-19 pandemic, the global Biopharmaceuticals Excipients market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by…
Biologics Contract Manufacturing Market – Scope of ReportTMR’s report on the global biologics contract manufacturing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market d…
Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Category (Biologics, Medical Devices), By Company Size (Medium, Large), By Indication, By Stage, By Services, By End Use, And Segment Forecasts, 2022 - 2030
Regulatory Affairs Outsourcing Market Growth & TrendsThe global regulatory affairs outsourcing market size is expected to reach USD 13.9 billion by 2030, registering a CAGR of 8.9% over the forecast period, according to a new report by Grand View Research…